I have led global, cross-functional teams responsible for advancing innovative therapies from early development through registration and commercialization, while building strategic partnerships across academia, biotechnology, investors, CROs and the pharmaceutical industry. My experience spans both scientific and commercial leadership, including portfolio strategy, external innovation, licensing, due diligence, biomarker-driven development, precision medicine and the integration of […]